MedTrace Logo

Pilot Study on Core Stabilization Training on Stable vs Unstable Surfaces in Young Rhythmic Gymnasts

NCT06966648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-07-17

No results posted yet for this study

Summary

This pilot randomized controlled trial will investigate the effects of a 7-week core stabilization program performed on stable versus unstable surfaces in young competitive rhythmic gymnasts. Sixteen athletes will be randomized into two groups and will be assessed for changes in static balance and pivot performance.

Conditions

  • Postural Balance
  • Motor Skills
  • Physical Fitness
  • Athletic Performance

Interventions

OTHER

Core stabilization on stable surfaces

Participants will perform a structured core stabilization training program on stable surfaces, such as the floor and rigid foam blocks. The program includes functional exercises targeting trunk control, postural alignment, and balance, delivered three times per week over a 7-week period.

OTHER

Core stabilization on unstable surfaces

Participants will perform the same structured core stabilization training program as the stable surface group, but on unstable surfaces such as BOSU balls and wobble boards. The intervention is designed to challenge balance, proprioception, and core muscle activation. Sessions are conducted three times per week over a 7-week period.

Sponsors & Collaborators

  • International Hellenic University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2025-07-15
Completion
2025-07-15

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06966648 on ClinicalTrials.gov